We are a boutique business growth and innovation agency, dedicated to delivering fresh insights, tackling strategic questions and implementing complex initiatives
As leaders across organizations are increasingly tasked with bringing strategic advice to the table, we help them to identify opportunities, develop ideas and turn growth plans into persuasive, bespoke, robust and actionable business cases that we can also help to execute
We
will turn
your growth
ideas
INTO
ACTION
WE ARE A THOUGHT PARTNER AND EXTENDED TEAM...
...TO A WIDE RANGE OF STAKEHOLDERS
.
In-depth qualitative and quantitative research
.
Advanced analytics and modeling
.
Strategic structuring and business case development
.
Effective and persuasive storytelling
.
Experienced implementation management and support
CEO AND MANAGING DIRECTORS
INNOVATION
TEAMS
BUSINESS
DEVELOPMENT TEAMS
BUSINESS INSIGHTS
AND ANALYTICS TEAMS
COMMERCIAL AND STRATEGIC
MARKETING TEAMS
STRATEGY & STRATEGIC PLANNING
TEAMS
SCOUTING AND PORTFOLIO
MANAGEMENT IN PEs and VCs
Finding adjacent product lines in the ICU for a global medical devices company
Business Case
Research
Insights
Storytelling
Healthcare
Growth
Finding the right business model for a disruptive nano-technology company.
Start-up
Deep-Tech
Nanotechnology
Business Plan
Research
Insights
Forecasting
Storytelling
Merging two pharma companies to create a regional leader
Merger
Integration
Synergies
Pharma
Analysis
Modelling
Finding the new ingredient for a global leading beverage company
Innovation
Beverages
Research
Structuring
Storytelling
Scouting
Insights
Finding the new ingredient for a global leading beverage company
Venture Capital
Start-ups
Investment
Growth
Innovation
Strategic due diligence and takeover plan of a flavours company for a PE firm in Latam
Flavours
Food & Beverages
Innovation
Growth
Acquisitions
Redefinition of OTC portfolio in 3 key European countries.
Research
Insights
Forecasting
Storytelling
Business Case
Workshop Facilitation
Multi-Country
Deciding to launch a high-cost drug biosimilar
High-price drugs
Biosimilars
Launch
Forecasting
Research
Interviews
